Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology ...

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel ...

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

TRUMP coin skyrocketed over 300 per cent on the first day, check out the cryptocurrency’s track record, and whether or not it ...

COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ ... to be traded on The Nasdaq Capital Market under the ticker symbol "EVAX." The ADS Ratio Change affects all shareholders ...

Evaxion Biotech changes ADS ratio from 1:10 to 1:50 ... be traded on The Nasdaq Capital Market under the existing ticker symbol “EVAX”, ensuring ongoing visibility and accessibility to ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program, despite their primary focus on hepatitis management. The company's market cap has surged past $1 billion ...

Shares of Sana Biotechnology surged after the company released what it assessed as positive data from a study of its in-development treatment for type 1 diabetes. The stock more than tripled ...